tradingkey.logo
tradingkey.logo
検索

Bionano Genomics Inc

BNGO
ウォッチリストに追加
1.150USD
-0.020-1.71%
終値 07/02, 13:00ET15分遅れの株価
12.35M時価総額
損失額直近12ヶ月PER

詳細情報 Bionano Genomics Inc 企業名

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Bionano Genomics Incの企業情報

企業コードBNGO
会社名Bionano Genomics Inc
上場日Aug 01, 2018
最高経営責任者「CEO」Holmlin (R. Erik)
従業員数98
証券種類Ordinary Share
決算期末Aug 01
本社所在地9540 Towne Centre Drive
都市SAN DIEGO
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号92121
電話番号18588887600
ウェブサイトhttps://bionano.com/
企業コードBNGO
上場日Aug 01, 2018
最高経営責任者「CEO」Holmlin (R. Erik)

Bionano Genomics Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
619.00
-4.36%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
254.00
-2.76%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
107.00
+84.11%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Kristiina Vuori, M.D., Ph.D.
Dr. Kristiina Vuori, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alka Chaubey, Ph.D.
Dr. Alka Chaubey, Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
619.00
-4.36%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
254.00
-2.76%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
107.00
+84.11%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--

よくある質問

Bionano Genomics Incの上位5名の株主は誰ですか?

Bionano Genomics Incの上位5名の株主は以下のとおりです。Mr. Mark Oldakowski

Bionano Genomics Inc(BNGO)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Bionano Genomics Incの株式を保有している機関は109社あり、保有株式の総市場価値は約1.17Mで、全体の10.52%を占めています。2025Q4と比較して、機関の持ち株は32263.00増加しています。

Bionano Genomics Incの最大の収益源は何ですか?

2026Q1において、Consumables部門がBionano Genomics Incにとって最大の収益を生み出しており、その金額は13.97Mで、全収益の49.00%を占めています。